Despite appearances, lean individuals can develop non-alcoholic fatty liver disease (NAFLD), now known as metabolic ...

This new review article highlights the critical role of ribosome biogenesis in liver health and disease progression.

As rates of MASLD, which is linked to obesity and diabetes, rise, new therapies have emerged, but better diagnostic and ...

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting ...

Researchers assess the ability of the Risk Estimation of Tumor REcurrence After Transplant score to predict recurrence of hepatocellular carcinoma in patients who underwent liver transplants as a ...

The fight against cancer in the country has received another major boost after Nairobi West Hospital announced that it had ...

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting ...

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting hepatocellular ...

Discover a study where results suggest that while MASLD is common in patients with T2DM in primary care, advanced liver ...

Non-Alcoholic Fatty Liver Disease (NAFLD) affects a significant portion of the global population, with prevalence varying by ...

The liver fibrosis market is entering a transformative phase, driven by greater awareness, improved diagnostic ...

E-Scopics' Ultraportable, Software-Based Hepatoscope In Use Across Leading Institutions and Clinics After successfully exhibiting its unique software-based liver assessment tool Hepatascope at the ...